AARDEX Group is dedicated to staying at the forefront of industry knowledge and expertise. That's why we regularly attend industry events and host webinars featuring top-tier experts in medication adherence. These webinars provide valuable insights and give attendees a front-row seat to the latest industry trends and developments.
LEARN WITH AARDEX GROUP
We are excited to offer on-demand and upcoming webinars focused on medication adherence. Our webinars feature industry-leading experts who provide actionable insights and strategies to improve medication adherence and ultimately, patient outcomes. Whether you are a healthcare provider, researcher, or patient, our webinars offer invaluable information and resources to help you better understand medication adherence and its importance in healthcare. Don't miss out on this opportunity to learn from the best in the field and stay up-to-date on the latest advancements in medication adherence. Register now for our upcoming webinars or access our on-demand webinars at any time.
Job Van Boven, Associate Professor, University Medical Center Groningen, and Bernard Vrijens, Scientific Lead, AARDEX Group
Matt Bolton of Merck and Ning Yu of Biogen
Ken Kaitin, TUFTS, John Musaus, Thermo Fisher and Timothy Peters-Strickland, PPD
WHERE TO FIND US NEXT
Our medication adherence experts are on a mission to change the game in clinical trials. They'll be taking our message to the people at several upcoming conferences. If you're ready to join the movement and revolutionize your approach to adherence in clinical trials, be sure to catch us at one of these events.
April 26-29, 2023, Phoenix, USA
May 3-4, 2023, Barcelona, Spain
May 21-24, 2023, Baltimore, Maryland
September 5-6, 2023, London, UK
October 3-4, 2023, Barcelona, Spain
October 5-7, 2023, London, UK
October 11-12, 2023, Pennsylvania, USA
October 31- November 2, Germany
November 8-11, 2023, Boston, USA
IN CONVERSATION WITH MERCK & BIOGEN
Mitigating the Risk of Poor Adherence in Trials
Watch this live recording with adherence experts from Merck & Biogen to learn about their approach to mitigating the risk of poor adherence in trials.
FROM THE AARDEX GROUP BLOG
We are thrilled to feature expert insights from Bernard Vrijens, a world-renowned expert on medication adherence. Taking medication as prescribed is crucial to achieving optimal health outcomes, yet non-adherence is a prevalent issue. Bernard Vrijens' extensive research and experience in the field provide invaluable insights into the factors that contribute to medication non-adherence and effective strategies to address them. His contributions to our medication adherence blog offer actionable advice and evidence-based recommendations to improve medication adherence and ultimately, patient outcomes.
It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,
In this article, Dr. Vrijens shares his thoughts on the need for dose optimization in the interests of balancing safety and efficacy. How we use language has a huge bearing on the meaning we convey. Take the word ‘overdose’, for
In this article, Dr. Bernard Vrijens discusses the importance of medication adherence data in clinical trials and why medication adherence should be a calculation, not an estimation. The world is today collecting a mind-blowing amount of data. Indeed, IDC calculates that about
In this article, our Scientific Lead, Bernard Vrijens, discusses the influence of medication non-adherence on ROI in clinical trials. Get ready for an insightful read! Fraught with risk yet pivotal to the future success of a drug candidate, clinical trials
This action, if finalized, will require applicants to create a new type of medication guide, referred to as Patient Medication Information (PMI). In this article, our Scientific Lead, Bernard Vrijens, unpacks the proposals and questions whether more is needed to
Adherence specialists join multi-stakeholder CancerX initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments. Liege, Belgium- July 18, 2023: Adherence specialist AARDEX Group is proud to announce it is a founding member of the CancerX initiative, bringing